Results 271 to 280 of about 2,792,307 (313)
Some of the next articles are maybe not open access.

Chromosomes in solid tumors

Virchows Archiv B Cell Pathology, 1978
Systematic chromosomal studies in solid tumors have been scanty (excepting meningiomas), because of the fact that it is difficult to obtain tumor material at desired times and only in about 10--15% of the cases adequate chromosome preparations are suitable with a direct technique or short term culture.
S, Kakati, A A, Sandberg
openaire   +2 more sources

Dasatinib in solid tumors

Expert Opinion on Investigational Drugs, 2010
Dasatinib is an oral, potent adenosine triphosphate-competitive inhibitor of multiple tyrosine kinases including BCR-ABL, c-KIT, platelet-derived growth factor receptor, and Src family kinases (SFKs). It has gained much attention for its use in chronic myeloid leukemia and for the treatment of adults with Philadelphia chromosome-positive acute ...
Lori C, Kim, Uwe, Rix, Eric B, Haura
openaire   +2 more sources

Autotransplantation in solid tumors

Blood Reviews, 1991
Studies are described of high-dose therapy in metastatic breast cancer, early stage breast cancer, stage IV neuroblastoma, recurrent or bulky disease testicular cancer and Ewing's sarcoma. The outcome in these subgroups with conventional therapy is described for comparison.
openaire   +2 more sources

Tumor Lysis Syndrome in Solid Tumors

Supportive Cancer Therapy, 2005
Tumor lysis syndrome (TLS) consists of acute hyperuricemic nephropathy, hyperphosphatemia, hypocalcemia, hyperkalemia, and increased serum creatinine. It can be part of the disease presentation, especially in aggressive hematologic malignancies, or a part of the chemotherapy response. There are relatively few reports of TLS in solid tumors.
Frank E, Mott   +3 more
openaire   +2 more sources

Benign Solid Tumors

Hand Clinics, 1987
The two most common solid benign tumors in the hand are lipoma and xanthoma, both painless; however, these tumors enlarge slowly until they are recognized (because of their unsightly appearance or interference with joint function) and treated.
openaire   +2 more sources

Solid Tumors in the Neonatal Period

Clinical Pediatrics, 2003
From 1972 to 2000, 123 patients with solid tumors whose complaints had started in the first 28 days of life were retrospectively evaluated. Fifty-five patients were diagnosed in the first 28 days and 68 patients were diagnosed after 28 days. In the former group, 85.5% of patients had symptoms in the first day of life. In the latter group, 77.9% had the
Tanyel, Cahit   +7 more
openaire   +3 more sources

Neonatal Malignant Solid Tumors

Tumori Journal, 1990
We reviewed the 8 malignant solid tumors in children less than 1 month of age observed at the Pediatric Surgical Department of Padua University from 1968 to 1985. These were 6 neuroblastomas, 1 Wilms' tumor and 1 angiosarcoma; 5/8 are alive without evidence of disease with a median follow-up of 8 years.
MESSINEO, ANTONIO   +4 more
openaire   +4 more sources

Immunotherapy of Solid Tumors

Surgical Clinics of North America, 1979
The concept of immunotherapy has evolved into a multifaceted and specialized concern. Nonspecific immunotherapy, for example, refers to the use of substances that randomly stimulate the host-immune response. Specific immunotherapy, in contrast, is intended to evoke a particular immune response against tumor antigens.
openaire   +2 more sources

Notch Signaling in Solid Tumors

2010
In recent years a substantial body of evidence derived from not only preclinical but also clinical studies has accumulated in support of Notch signaling playing important oncogenic roles in several types of cancer. The finding that activating Notch mutations are frequently found in patients suffering from acute lymphoblastic leukemia is one of the best
Koch, Ute, Radtke, Freddy
openaire   +4 more sources

Modulation of tumor associated macrophages in solid tumors

Frontiers in Bioscience, 2008
It is becoming increasingly clear that interactions between cancer cells, stroma cells and the extracellular matrix (ECM) are pivotal to the processes of neovascularization and tumorigenesis. As tumor stromal components known as tumor associated macrophages (TAMs), mononuclear phagocytes can play a key role in tumor type specific neoangiogenesis by ...
Trevor, Lucas   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy